Corcept Therapeutics (CORT) News Today $71.88 -1.35 (-1.84%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Corcept Therapeutics (NASDAQ:CORT) Shares Gap Up - Here's WhyCorcept Therapeutics (NASDAQ:CORT) Shares Gap Up - Should You Buy?April 30 at 12:17 PM | marketbeat.comDimensional Fund Advisors LP Has $104.74 Million Stake in Corcept Therapeutics Incorporated (NASDAQ:CORT)Dimensional Fund Advisors LP reduced its holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 17.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,078,568 shares of the biotechnology companyApril 29 at 4:29 AM | marketbeat.comGuggenheim Capital LLC Acquires Shares of 5,575 Corcept Therapeutics Incorporated (NASDAQ:CORT)Guggenheim Capital LLC purchased a new position in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 5,575 shares of the biotechnology company's stock, valuApril 29 at 4:08 AM | marketbeat.comHancock Whitney Corp Sells 4,733 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)Hancock Whitney Corp lessened its position in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 20.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 18,221 shares of the biotechnology comApril 28 at 5:55 AM | marketbeat.comPiper Sandler Reaffirms Their Buy Rating on Corcept Therapeutics (CORT)April 26, 2025 | markets.businessinsider.comCANADA LIFE ASSURANCE Co Buys 15,838 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)CANADA LIFE ASSURANCE Co increased its stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 17.8% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 104,734 shares of the biotechnology company's stock afterApril 26, 2025 | marketbeat.comFirst Trust Advisors LP Reduces Stake in Corcept Therapeutics Incorporated (NASDAQ:CORT)First Trust Advisors LP reduced its stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 19.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,064,122 shares of the biotechnology compaApril 25, 2025 | marketbeat.comJump Financial LLC Purchases Shares of 14,242 Corcept Therapeutics Incorporated (NASDAQ:CORT)Jump Financial LLC acquired a new position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 14,242 shares of the biotechnology company's stock, vaApril 25, 2025 | marketbeat.comMassar Capital Management LP Purchases New Shares in Corcept Therapeutics Incorporated (NASDAQ:CORT)Massar Capital Management LP acquired a new position in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 29,192 shares of the biotechnology company's stApril 24, 2025 | marketbeat.comIs Corcept Therapeutics Incorporated (CORT) Among the Best Guru Stocks to Buy According to Wall Street Analysts?April 23, 2025 | insidermonkey.comCorcept Therapeutics to Present Phase 3 Trial Data at ASCO 2025 | CORT stock newsApril 23, 2025 | gurufocus.comCORCEPT TO PRESENT LATE-BREAKING DATA FROM PIVOTAL PHASE 3 ROSELLA TRIAL OF RELACORILANT IN PLATINUM-RESISTANT OVARIAN CANCER AT ASCO 2025April 23, 2025 | businesswire.comCorcept: Maintaining Strong Buy Even After 4Q Revenue And Earnings MissApril 22, 2025 | seekingalpha.comWells Fargo & Company MN Buys 46,067 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)Wells Fargo & Company MN grew its stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 104.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 90,137 shares of the biotechnoloApril 22, 2025 | marketbeat.comDiabetes Care Publishes Results From Prevalence Phase Of Corcept’s CATALYST Trial In People With Difficult-To-Control Type 2 DiabetesApril 21, 2025 | finance.yahoo.com13,657 Shares in Corcept Therapeutics Incorporated (NASDAQ:CORT) Purchased by XTX Topco LtdXTX Topco Ltd purchased a new stake in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 13,657 shares of the biotechnology company's stock, valApril 20, 2025 | marketbeat.comCorcept Therapeutics Incorporated (NASDAQ:CORT) Shares Sold by Invesco Ltd.Invesco Ltd. reduced its stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 17.6% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 706,133 shares of the biotechnology company's stock after selling 151,225 shApril 19, 2025 | marketbeat.comFederated Hermes Inc. Boosts Stake in Corcept Therapeutics Incorporated (NASDAQ:CORT)Federated Hermes Inc. raised its holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 107.1% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 13,870 shares of the bioteApril 19, 2025 | marketbeat.comCorcept Therapeutics (NASDAQ:CORT) Stock Price Down 5.3% - Here's WhyCorcept Therapeutics (NASDAQ:CORT) Stock Price Down 5.3% - Here's What HappenedApril 18, 2025 | marketbeat.comAdvisory Services Network LLC Reduces Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)Advisory Services Network LLC reduced its position in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 24.1% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 15,658 shares of the biotechnology company's stock after selling 4,976April 17, 2025 | marketbeat.com$1000 Invested In Corcept Therapeutics 20 Years Ago Would Be Worth This Much TodayApril 17, 2025 | benzinga.comInsider Selling: Corcept Therapeutics Incorporated (NASDAQ:CORT) Director Sells 2,200 Shares of StockCorcept Therapeutics Incorporated (NASDAQ:CORT - Get Free Report) Director Daniel N. Swisher, Jr. sold 2,200 shares of Corcept Therapeutics stock in a transaction on Thursday, April 10th. The shares were sold at an average price of $70.22, for a total transaction of $154,484.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.April 16, 2025 | marketbeat.comIt's Still Early For Corcept: With Multiple Growth Opportunities Ahead, It's No Longer Just A One Drug WonderApril 15, 2025 | seekingalpha.comCapital Fund Management S.A. Decreases Stock Position in Corcept Therapeutics Incorporated (NASDAQ:CORT)Capital Fund Management S.A. decreased its position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 19.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor ownedApril 15, 2025 | marketbeat.comJPMorgan Chase & Co. Increases Stock Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)JPMorgan Chase & Co. increased its stake in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 2.7% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 259,902 shares of the biotechnology company's stock after acquirinApril 15, 2025 | marketbeat.comRussell Investments Group Ltd. Purchases 21,281 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)Russell Investments Group Ltd. raised its position in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 11.7% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 202,504 shares of the biotechnology company's stock after acquirinApril 14, 2025 | marketbeat.comAviva PLC Cuts Stock Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)Aviva PLC lowered its stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 36.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,956 shares of the biotechnology company'April 14, 2025 | marketbeat.comLPL Financial LLC Grows Stake in Corcept Therapeutics Incorporated (NASDAQ:CORT)LPL Financial LLC lifted its stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 47.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 60,682 shares of the biotechnology company'April 14, 2025 | marketbeat.comAlliancebernstein L.P. Cuts Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)Alliancebernstein L.P. reduced its position in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 8.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 170,869 shares of the biotechnoApril 13, 2025 | marketbeat.comCorcept Therapeutics Incorporated (NASDAQ:CORT) Given Consensus Recommendation of "Buy" by AnalystsShares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Get Free Report) have earned an average rating of "Buy" from the five research firms that are covering the firm, Marketbeat Ratings reports. Five investment analysts have rated the stock with a buy rating. The average 1 year price objectivApril 13, 2025 | marketbeat.comCorcept Therapeutics Incorporated (NASDAQ:CORT) Shares Sold by Geode Capital Management LLCGeode Capital Management LLC lowered its holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 13.1% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,068,175 shares of the biotechnology company's stock after sellApril 12, 2025 | marketbeat.comCorcept Therapeutics (NASDAQ:CORT) Trading Down 5.7% - Here's What HappenedCorcept Therapeutics (NASDAQ:CORT) Shares Down 5.7% - Here's WhyApril 11, 2025 | marketbeat.comShelton Capital Management Sells 10,867 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)Shelton Capital Management reduced its position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 7.8% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 128,914 shares of the biotechnology companApril 11, 2025 | marketbeat.comCerity Partners LLC Has $30.60 Million Stake in Corcept Therapeutics Incorporated (NASDAQ:CORT)Cerity Partners LLC reduced its position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 0.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 607,946 shares of the bioteApril 11, 2025 | marketbeat.comRenaissance Technologies LLC Has $312.35 Million Stock Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)Renaissance Technologies LLC lowered its position in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 4.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,198,602 sharesApril 10, 2025 | marketbeat.com3 Biopharmaceutical Stocks Bucking the Sell-Off (CORT)Three biopharma companies may appeal to investors looking for firms that have not been rocked by tariff-inspired turbulence.April 10, 2025 | marketbeat.comCorcept Therapeutics (NasdaqCM:CORT) Rises 36% in Last QuarterApril 9, 2025 | finance.yahoo.comCorcept Therapeutics Incorporated (NASDAQ:CORT) Shares Sold by Headlands Technologies LLCHeadlands Technologies LLC trimmed its stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 84.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,117 shares of the biotechnologApril 9, 2025 | marketbeat.comFranklin Resources Inc. Raises Stake in Corcept Therapeutics Incorporated (NASDAQ:CORT)Franklin Resources Inc. increased its holdings in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 12.8% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 273,974 shares of the biotechnology company'sApril 9, 2025 | marketbeat.comCorcept Therapeutics initiates trial of Phase 2 trial BELLAApril 8, 2025 | markets.businessinsider.comPitcairn Co. Takes Position in Corcept Therapeutics Incorporated (NASDAQ:CORT)Pitcairn Co. bought a new position in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 4,138 shares of the biotechnology company's stock, valued at approximately $209,000. Other larApril 8, 2025 | marketbeat.com65,113 Shares in Corcept Therapeutics Incorporated (NASDAQ:CORT) Purchased by Trexquant Investment LPTrexquant Investment LP bought a new stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 65,113 shares of the biotechnologApril 8, 2025 | marketbeat.comZacks Research Issues Optimistic Estimate for CORT EarningsCorcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) - Investment analysts at Zacks Research upped their Q1 2026 EPS estimates for Corcept Therapeutics in a research note issued on Wednesday, April 2nd. Zacks Research analyst K. Das now forecasts that the biotechnology company will postApril 8, 2025 | marketbeat.comCorcept Initiates Trial of Relacorilant Plus Nab-Paclitaxel and Bevacizumab in Patients With Platinum-Resistant Ovarian CancerApril 7, 2025 | finance.yahoo.com10,905 Shares in Corcept Therapeutics Incorporated (NASDAQ:CORT) Bought by Atlas Capital Advisors Inc.Atlas Capital Advisors Inc. bought a new stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 10,905 shares of the biotechnologyApril 7, 2025 | marketbeat.comZacks Research Brokers Increase Earnings Estimates for CORTCorcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) - Equities research analysts at Zacks Research boosted their Q2 2026 earnings per share estimates for shares of Corcept Therapeutics in a research note issued on Wednesday, April 2nd. Zacks Research analyst K. Das now anticipates thatApril 6, 2025 | marketbeat.comIntegrated Quantitative Investments LLC Takes Position in Corcept Therapeutics Incorporated (NASDAQ:CORT)Integrated Quantitative Investments LLC acquired a new position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investorApril 6, 2025 | marketbeat.comNorges Bank Takes Position in Corcept Therapeutics Incorporated (NASDAQ:CORT)Norges Bank purchased a new stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 834,591 shares of the biotechnology company's stock, valued at approximately $April 6, 2025 | marketbeat.comCorcept Therapeutics (NASDAQ:CORT) Given New $131.00 Price Target at Piper SandlerPiper Sandler upped their price target on Corcept Therapeutics from $128.00 to $131.00 and gave the company an "overweight" rating in a report on Thursday.April 5, 2025 | marketbeat.comWhat is HC Wainwright's Estimate for CORT FY2026 Earnings?Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) - Stock analysts at HC Wainwright increased their FY2026 EPS estimates for Corcept Therapeutics in a research note issued to investors on Monday, March 31st. HC Wainwright analyst S. Ramakanth now anticipates that the biotechnology comApril 5, 2025 | marketbeat.com Get Corcept Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CORT and its competitors with MarketBeat's FREE daily newsletter. Email Address CORT Media Mentions By Week CORT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CORT News Sentiment▼1.280.85▲Average Medical News Sentiment CORT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CORT Articles This Week▼118▲CORT Articles Average Week Get Corcept Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CORT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Royalty Pharma News Today Jazz Pharmaceuticals News Today Perrigo News Today Supernus Pharmaceuticals News Today Pacira BioSciences News Today Omeros News Today Nektar Therapeutics News Today Assembly Biosciences News Today Cumberland Pharmaceuticals News Today Eli Lilly and Company News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CORT) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corcept Therapeutics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Corcept Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CORT Stock Free CORT Stock Alerts